{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T22:49:26Z","timestamp":1775861366940,"version":"3.50.1"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s13193-022-01683-8","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:11:17Z","timestamp":1669900277000},"page":"131-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extrapelvic Endometriosis Mimicking Peritoneal Surface Malignancy: Case Report and a Review of Literature"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-6882","authenticated-orcid":false,"given":"Marie","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Meylaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-4784","authenticated-orcid":false,"given":"Kim","family":"Govaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/HUMREP\/DET457","volume":"29","author":"GAJ Dunselman","year":"2014","unstructured":"Dunselman GAJ, Vermeulen N, Becker C et al (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29:400\u2013412. https:\/\/doi.org\/10.1093\/HUMREP\/DET457","journal-title":"Hum Reprod"},{"key":"1683_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jmig.2019.10.004","volume":"27","author":"MP Andres","year":"2020","unstructured":"Andres MP, Arcoverde FVL, Souza CCC et al (2020) Extrapelvic endometriosis: a systematic review. J Minim Invasive Gynecol 27:373\u2013389. https:\/\/doi.org\/10.1016\/j.jmig.2019.10.004","journal-title":"J Minim Invasive Gynecol"},{"key":"1683_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/J.EJOGRB.2017.08.019","volume":"217","author":"M Matalliotakis","year":"2017","unstructured":"Matalliotakis M, Goulielmos GN, Kalogiannidis I et al (2017) Extra pelvic endometriosis: retrospective analysis on 200 cases in two different countries. Eur J Obstet Gynecol Reprod Biol 217:34\u201337. https:\/\/doi.org\/10.1016\/J.EJOGRB.2017.08.019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"93\u2013110","key":"1683_CR4","first-page":"43","volume":"3","author":"JA Sampson","year":"1927","unstructured":"Sampson JA (1927) Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 3(93\u2013110):43","journal-title":"Am J Pathol"},{"issue":"250","key":"1683_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF01891397","volume":"2503","author":"R Meyer","year":"1924","unstructured":"Meyer R (1924)\u00a0Zur Frage der heterotopen Epithelwucherung, insbesondere des Peritonealepithels und in den Ovarien. Virchows Arch f\u00fcr Pathol Anat und Physiol und f\u00fcr Klin Medizin 2503(250):595\u2013610. https:\/\/doi.org\/10.1007\/BF01891397","journal-title":"Virchows Arch f\u00fcr Pathol Anat und Physiol und f\u00fcr Klin Medizin"},{"key":"1683_CR6","first-page":"617","volume":"33","author":"BR Ferguson","year":"1969","unstructured":"Ferguson BR, Bennington JL, Haber SL (1969) Histochemistry of mucosubstances and histology of mixed M\u00fcllerian pelvic lymph node glandular inclusions: evidence for histogenesis by m\u00fcllerian metaplasia of coelomic epithelium. Obstet Gynecol 33:617\u2013625","journal-title":"Obstet Gynecol"},{"key":"1683_CR7","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/HUMREP\/DEN259","volume":"23","author":"S Mechsner","year":"2008","unstructured":"Mechsner S, Weichbrodt M, Riedlinger WFJ et al (2008) Estrogen and progestogen receptor positive endometriotic lesions and disseminated cells in pelvic sentinel lymph nodes of patients with deep infiltrating rectovaginal endometriosis: a pilot study. Hum Reprod 23:2202\u20132209. https:\/\/doi.org\/10.1093\/HUMREP\/DEN259","journal-title":"Hum Reprod"},{"issue":"24","key":"1683_CR8","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJM199306173282407","volume":"328","author":"DL Olive","year":"1993","unstructured":"Olive DL, Schwartz LB (1993) Endometriosis. N Engl J Med 328(24):1759\u20131769. https:\/\/doi.org\/10.1056\/NEJM199306173282407","journal-title":"N Engl J Med"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/GRF.0B013E3181DB7CE8","volume":"53","author":"AL Hsu","year":"2010","unstructured":"Hsu AL, Khachikyan I, Stratton P (2010) Invasive and noninvasive methods for the diagnosis of endometriosis. Clin Obstet Gynecol 53:413\u2013419. https:\/\/doi.org\/10.1097\/GRF.0B013E3181DB7CE8","journal-title":"Clin Obstet Gynecol"},{"key":"1683_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3461209","volume":"2018","author":"D Charatsi","year":"2018","unstructured":"Charatsi D, Koukoura O, Ntavela IG et al (2018) Gastrointestinal and urinary tract endometriosis: a review on the commonest locations of extrapelvic endometriosis. Adv Med 2018:1\u201311. https:\/\/doi.org\/10.1155\/2018\/3461209","journal-title":"Adv Med"},{"key":"1683_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1148\/RG.326125518","volume":"32","author":"ES Siegelman","year":"2012","unstructured":"Siegelman ES, Oliver ER (2012) MR imaging of endometriosis: ten imaging pearls. Radiographics 32:1675\u20131691. https:\/\/doi.org\/10.1148\/RG.326125518","journal-title":"Radiographics"},{"key":"1683_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","volume":"24","author":"CL Pearce","year":"2015","unstructured":"Pearce CL, Stram DO, Ness RB et al (2015) Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev 24:671\u2013676. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-1128","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/J.YGYNO.2011.10.001","volume":"124","author":"PS Munksgaard","year":"2012","unstructured":"Munksgaard PS, Blaakaer J (2012) The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 124:164\u2013169. https:\/\/doi.org\/10.1016\/J.YGYNO.2011.10.001","journal-title":"Gynecol Oncol"},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/J.YGYNO.2005.11.033","volume":"101","author":"E Somigliana","year":"2006","unstructured":"Somigliana E, Vigano P, Parazzini F et al (2006) Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol 101:331\u2013341. https:\/\/doi.org\/10.1016\/J.YGYNO.2005.11.033","journal-title":"Gynecol Oncol"},{"key":"1683_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/PGP.0B013E31821F4B85","volume":"30","author":"JJ Wei","year":"2011","unstructured":"Wei JJ, William J, Bulun S (2011) Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol 30:553\u2013568. https:\/\/doi.org\/10.1097\/PGP.0B013E31821F4B85","journal-title":"Int J Gynecol Pathol"},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/J.EJSO.2020.01.032","volume":"47","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, Mohamed F, Glehen O, Passot G (2021) Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy. Eur J Surg Oncol 47:60\u201364. https:\/\/doi.org\/10.1016\/J.EJSO.2020.01.032","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"1683_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14712\/18059694.2014.47","volume":"57","author":"A Kucuk","year":"2014","unstructured":"Kucuk A, Gezer IA, Ucar R, Karahan AY (2014) Familial mediterranean fever. Acta Med (Hradec Kralove) 57(3):97\u2013104. https:\/\/doi.org\/10.14712\/18059694.2014.47","journal-title":"Acta Med (Hradec Kralove)"},{"issue":"37","key":"1683_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/S00281-015-0484-6","volume":"374","author":"S Ozen","year":"2015","unstructured":"Ozen S (2015) Batu ED (2015) The myths we believed in familial Mediterranean fever: what have we learned in the past years? Semin Immunopathol 374(37):363\u2013369. https:\/\/doi.org\/10.1007\/S00281-015-0484-6","journal-title":"Semin Immunopathol"},{"key":"1683_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/S10067-017-3715-5\/FIGURES\/2","volume":"36","author":"M Alghamdi","year":"2017","unstructured":"Alghamdi M (2017) Familial Mediterranean fever, review of the literature. Clin Rheumatol 36:1707\u20131713. https:\/\/doi.org\/10.1007\/S10067-017-3715-5\/FIGURES\/2","journal-title":"Clin Rheumatol"},{"key":"1683_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/ANNRHEUMDIS-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644\u2013651. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2015-208690","journal-title":"Ann Rheum Dis"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-18-0203\/69505\/AM\/CHRONIC-MEDICAL-CONDITIONS-AND-CA125-LEVELS-AMONG","volume":"27","author":"BO Akinwunmi","year":"2018","unstructured":"Akinwunmi BO, Babic A, Vitonis AF et al (2018) Chronic medical conditions and CA125 levels among women without ovarian cancer. Cancer Epidemiol Biomarkers Prev 27:1483\u20131490. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0203\/69505\/AM\/CHRONIC-MEDICAL-CONDITIONS-AND-CA125-LEVELS-AMONG","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1683_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/HUMUPD\/1.2.173","volume":"1","author":"M Muyldermans","year":"1995","unstructured":"Muyldermans M, Cornillie FJ, Koninckx PR (1995) CA125 and endometriosis. Hum Reprod Update 1:173\u2013187. https:\/\/doi.org\/10.1093\/HUMUPD\/1.2.173","journal-title":"Hum Reprod Update"},{"key":"1683_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.7314\/APJCP.2016.17.1.323","volume":"17","author":"A Fawzy","year":"2016","unstructured":"Fawzy A, Mohamed MR, Ali MAM et al (2016) Tissue CA125 and HE4 gene expression levels offer superior accuracy in discriminating benign from malignant pelvic masses. Asian Pac J Cancer Prev 17:323\u2013333. https:\/\/doi.org\/10.7314\/APJCP.2016.17.1.323","journal-title":"Asian Pac J Cancer Prev"},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/JCP.2004.018077","volume":"58","author":"EL Moss","year":"2005","unstructured":"Moss EL, Hollingworth J, Reynolds TM (2005) The role of CA125 in clinical practice. J Clin Pathol 58:308. https:\/\/doi.org\/10.1136\/JCP.2004.018077","journal-title":"J Clin Pathol"},{"issue":"5","key":"1683_CR25","doi-asserted-by":"publisher","first-page":"CD012179","DOI":"10.1002\/14651858.CD012179","volume":"2016","author":"V Nisenblat","year":"2016","unstructured":"Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, Mol BW, Johnson N, Hull ML (2016) Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016(5):CD012179. https:\/\/doi.org\/10.1002\/14651858.CD012179","journal-title":"Cochrane Database Syst Rev"},{"key":"1683_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/J.1471-0528.2004.00433.X","volume":"111","author":"CB Wykes","year":"2004","unstructured":"Wykes CB, Clark TJ, Khan KS (2004) Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG 111:1204\u20131212. https:\/\/doi.org\/10.1111\/J.1471-0528.2004.00433.X","journal-title":"BJOG"},{"issue":"3","key":"1683_CR27","doi-asserted-by":"publisher","first-page":"CD010360","DOI":"10.1002\/14651858.CD010360.pub2","volume":"3","author":"ND Ratnavelu","year":"2016","unstructured":"Ratnavelu ND, Brown AP, Mallett S, Scholten RJ, Patel A, Founta C, Galaal K, Cross P, Naik R (2016) Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. Cochrane Database Syst Rev 3(3):CD010360. https:\/\/doi.org\/10.1002\/14651858.CD010360.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1683_CR28","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e95","volume":"30","author":"JY Park","year":"2019","unstructured":"Park JY, Lee SH, Kim KR, Kim YT, Nam JH (2019) Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors. J Gynecol Oncol 30(6):e95. https:\/\/doi.org\/10.3802\/jgo.2019.30.e95","journal-title":"J Gynecol Oncol"},{"key":"1683_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/DC.24721","volume":"49","author":"J Eleut\u00e9rio","year":"2021","unstructured":"Eleut\u00e9rio J, Md J, Francisco Medeiros C (2021) Peritoneal lavage cytology in the diagnosis of pelvic endometriosis. Diagn Cytopathol 49:677\u2013681. https:\/\/doi.org\/10.1002\/DC.24721","journal-title":"Diagn Cytopathol"},{"key":"1683_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/CRJ.13166","volume":"14","author":"J Almeida Santos","year":"2020","unstructured":"Almeida Santos J, Duarte R, Nunes C (2020) Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis. Clin Respir J 14:541\u2013548. https:\/\/doi.org\/10.1111\/CRJ.13166","journal-title":"Clin Respir J"},{"key":"1683_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-4613-1245-1_18\/COVER\/","volume":"81","author":"ME Kass","year":"1996","unstructured":"Kass ME (1996) Pathology of peritoneal mesothelioma. Cancer Treat Res 81:213\u2013225. https:\/\/doi.org\/10.1007\/978-1-4613-1245-1_18\/COVER\/","journal-title":"Cancer Treat Res"},{"issue":"10","key":"1683_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00000478-198810000-00001","volume":"12","author":"SW Weiss","year":"1988","unstructured":"Weiss SW, Tavassoli FA (1988) Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 12(10):737\u2013746","journal-title":"Am J Surg Pathol"},{"key":"1683_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ANNONC\/MDP307","volume":"21","author":"MV de Pangher","year":"2010","unstructured":"de Pangher MV, Recchia L, Cafferata M et al (2010) Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol 21:348\u2013353. https:\/\/doi.org\/10.1093\/ANNONC\/MDP307","journal-title":"Ann Oncol"},{"key":"1683_CR34","first-page":"32","volume":"9","author":"B Alessio","year":"2007","unstructured":"Alessio B, Padoan I, Mencarelli R, Frego M (2007) Peritoneal mesothelioma: a review. Medscape Gen Med 9:32","journal-title":"Medscape Gen Med"},{"key":"1683_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/ANNONC\/MDL345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol Off J Eur Soc Med Oncol 18:985\u2013990. https:\/\/doi.org\/10.1093\/ANNONC\/MDL345","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"1683_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.EJSO.2020.02.011","volume":"47","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Kepenekian V, Villeneuve L et al (2021) Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 47:36\u201359. https:\/\/doi.org\/10.1016\/J.EJSO.2020.02.011","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"1683_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2559.1997.2510855.x","volume":"31","author":"E Almud\u00e9var Bercero","year":"1997","unstructured":"Almud\u00e9var Bercero E, Garc\u00eda-Rost\u00e1n P\u00e9rez GM, Garc\u00eda Bragado F, Jim\u00e9nez C (1997) Prognostic value of high serum levels of CA-125 in malignant secretory peritoneal mesotheliomas affecting young women. A case report with differential diagnosis and review of the literature. Histopathology 31(3):267\u2013273. https:\/\/doi.org\/10.1046\/j.1365-2559.1997.2510855.x","journal-title":"Histopathology"},{"key":"1683_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/JCLINPATH-2012-201303","volume":"66","author":"DW Henderson","year":"2013","unstructured":"Henderson DW, Reid G, Kao SC et al (2013) Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. J Clin Pathol 66:847\u2013853. https:\/\/doi.org\/10.1136\/JCLINPATH-2012-201303","journal-title":"J Clin Pathol"},{"key":"1683_CR39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.5858\/133.8.1317","volume":"133","author":"AN Husain","year":"2009","unstructured":"Husain AN, Colby TV, Ord\u00f3\u00f1ez NG et al (2009) Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 133:1317\u20131331. https:\/\/doi.org\/10.5858\/133.8.1317","journal-title":"Arch Pathol Lab Med"},{"key":"1683_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/ARPA.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ord\u00f3\u00f1ez NG et al (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142:89\u2013108. https:\/\/doi.org\/10.5858\/ARPA.2017-0124-RA","journal-title":"Arch Pathol Lab Med"},{"key":"1683_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/CNCY.21392","volume":"122","author":"VY Jo","year":"2014","unstructured":"Jo VY, Cibas ES, Pinkus GS (2014) Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology. Cancer Cytopathol 122:299\u2013306. https:\/\/doi.org\/10.1002\/CNCY.21392","journal-title":"Cancer Cytopathol"},{"key":"1683_CR42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/S00428-007-0448-X","volume":"451","author":"F Facchetti","year":"2007","unstructured":"Facchetti F, Lonardi S, Gentili F et al (2007) Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch 451:669\u2013680. https:\/\/doi.org\/10.1007\/S00428-007-0448-X","journal-title":"Virchows Arch"},{"key":"1683_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/JCLINPATH-2015-203211","volume":"69","author":"T Kawai","year":"2016","unstructured":"Kawai T, Tominaga S, Hiroi S et al (2016) Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses. J Clin Pathol 69:706\u2013712. https:\/\/doi.org\/10.1136\/JCLINPATH-2015-203211","journal-title":"J Clin Pathol"},{"key":"1683_CR44","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP et al (2015) Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 10:1240\u20131242. https:\/\/doi.org\/10.1097\/JTO.0000000000000663","journal-title":"J Thorac Oncol"},{"key":"1683_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D et al (2006) Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 13:229\u2013237. https:\/\/doi.org\/10.1245\/ASO.2006.03.045","journal-title":"Ann Surg Oncol"},{"key":"1683_CR46","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237\u20136242. https:\/\/doi.org\/10.1200\/JCO.2009.23.9640","journal-title":"J Clin Oncol"},{"key":"1683_CR47","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1245\/S10434-015-4962-9","volume":"23","author":"S Kusamura","year":"2016","unstructured":"Kusamura S, Torres Mesa PA, Cabras A et al (2016) The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23:1468\u20131473. https:\/\/doi.org\/10.1245\/S10434-015-4962-9","journal-title":"Ann Surg Oncol"},{"key":"1683_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","volume":"38","author":"T Berghmans","year":"2002","unstructured":"Berghmans T, Paesmans M, Lalami Y et al (2002) Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer 38:111\u2013121. https:\/\/doi.org\/10.1016\/S0169-5002(02)00180-0","journal-title":"Lung Cancer"},{"key":"1683_CR49","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/S10434-014-3978-X","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA et al (2015) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol 22:1686\u20131693. https:\/\/doi.org\/10.1245\/S10434-014-3978-X","journal-title":"Ann Surg Oncol"},{"key":"1683_CR50","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/J.EJSO.2017.01.009","volume":"43","author":"PH Sugarbaker","year":"2017","unstructured":"Sugarbaker PH, Chang D (2017) Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. Eur J Surg Oncol 43:1228\u20131235. https:\/\/doi.org\/10.1016\/J.EJSO.2017.01.009","journal-title":"Eur J Surg Oncol"},{"key":"1683_CR51","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644. https:\/\/doi.org\/10.1200\/JCO.2003.11.136","journal-title":"J Clin Oncol"},{"key":"1683_CR52","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, Verschraegen CF, J\u00e4nne PA et al (2008) Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol 26:3567\u20133572. https:\/\/doi.org\/10.1200\/JCO.2007.15.2868","journal-title":"J Clin Oncol"},{"issue":"5","key":"1683_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026779","volume":"9","author":"NL de Boer","year":"2019","unstructured":"de Boer NL, van Kooten JP, Burger JWA, Verhoef C, Aerts JGJV, Madsen EVE (2019) Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single Centre open-label clinical trial: rationale and design of the MESOPEC trial. BMJ Open 9(5):e026779. https:\/\/doi.org\/10.1136\/bmjopen-2018-026779","journal-title":"BMJ Open"},{"key":"1683_CR54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1245\/S10434-017-6293-5","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, Sugarbaker P, Deraco M et al (2018) Is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. Ann Surg Oncol 25:667\u2013673. https:\/\/doi.org\/10.1245\/S10434-017-6293-5","journal-title":"Ann Surg Oncol"},{"key":"1683_CR55","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1158\/2159-8290.CD-21-0331\/673853\/AM\/EFFICACY-SAFETY-AND-BIOMARKER-ANALYSIS-OF-COMBINED","volume":"11","author":"K Raghav","year":"2021","unstructured":"Raghav K, Liu S, Overman MJ et al (2021) Efficacy, safety, and biomarker analysis of combined pd-l1 (Atezolizumab) and vegf (bevacizumab) blockade in advanced mesothelioma. Cancer Discov 11:2738\u20132747. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0331\/673853\/AM\/EFFICACY-SAFETY-AND-BIOMARKER-ANALYSIS-OF-COMBINED","journal-title":"Cancer Discov"},{"key":"1683_CR56","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/J.EJSO.2010.08.130","volume":"36","author":"D Baratti","year":"2010","unstructured":"Baratti D, Vaira M, Kusamura S et al (2010) Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Eur J Surg Oncol 36:1047\u20131053. https:\/\/doi.org\/10.1016\/J.EJSO.2010.08.130","journal-title":"Eur J Surg Oncol"},{"key":"1683_CR57","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.3748\/WJG.V12.I35.5739","volume":"12","author":"MC Safioleas","year":"2006","unstructured":"Safioleas MC, Constantinos K, Michael S et al (2006) Benign multicystic peritoneal mesothelioma: a case report and review of the literature. World J Gastroenterol 12:5739. https:\/\/doi.org\/10.3748\/WJG.V12.I35.5739","journal-title":"World J Gastroenterol"},{"key":"1683_CR58","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/S12253-009-9170-0","volume":"15","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yao P, Akther J et al (2009) Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma. Pathol Oncol Res 15:671\u2013678. https:\/\/doi.org\/10.1007\/S12253-009-9170-0","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"1683_CR59","doi-asserted-by":"publisher","first-page":"20190024","DOI":"10.1515\/pp-2019-0024","volume":"4","author":"B Noiret","year":"2019","unstructured":"Noiret B, Renaud F, Piessen G, Eveno C (2019) Multicystic peritoneal mesothelioma: a systematic review of the literature. Pleura and Peritoneum 4(3):20190024. https:\/\/doi.org\/10.1515\/pp-2019-0024","journal-title":"Pleura and Peritoneum"},{"issue":"2","key":"1683_CR60","doi-asserted-by":"publisher","first-page":"zraa001","DOI":"10.1093\/bjsopen\/zraa001","volume":"5","author":"A Zahid","year":"2021","unstructured":"Zahid A, Clarke L, Carr N, Chandrakumaran K, Tzivanakis A, Dayal S, Mohamed F, Cecil T, Moran BJ (2021) Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open 5(2):zraa001. https:\/\/doi.org\/10.1093\/bjsopen\/zraa001","journal-title":"BJS Open"},{"key":"1683_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.EJSO.2020.02.012","volume":"47","author":"K Govaerts","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh IHJT et al (2021) Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 47:11\u201335. https:\/\/doi.org\/10.1016\/J.EJSO.2020.02.012","journal-title":"Eur J Surg Oncol"},{"key":"1683_CR62","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","volume":"38","author":"A Churg","year":"2014","unstructured":"Churg A, Allen T, Borczuk AC et al (2014) Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol 38:990\u2013998. https:\/\/doi.org\/10.1097\/PAS.0000000000000200","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1683_CR63","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::aid-cncr2820650218>3.0.co;2-w","volume":"65","author":"D Daya","year":"1990","unstructured":"Daya D, McCaughey WT (1990) Well-differentiated papillary mesothelioma of the peritoneum. A clinico pathologic study of 22 cases. Cancer 65(2):292\u2013296. https:\/\/doi.org\/10.1002\/1097-0142(19900115)65:2<292::aid-cncr2820650218>3.0.co;2-w","journal-title":"Cancer"},{"key":"1683_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/PAS.0B013E3182354A79","volume":"36","author":"A Malpica","year":"2012","unstructured":"Malpica A, Sant\u2019 Ambrogio S, Deavers MT, Silva EG (2012) Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol 36:117\u2013127. https:\/\/doi.org\/10.1097\/PAS.0B013E3182354A79","journal-title":"Am J Surg Pathol"},{"key":"1683_CR65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/HIS.12089","volume":"62","author":"X Chen","year":"2013","unstructured":"Chen X, Sheng W, Wang J (2013) Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology 62:805\u2013813. https:\/\/doi.org\/10.1111\/HIS.12089","journal-title":"Histopathology"},{"key":"1683_CR66","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.YGYNO.2005.03.031","volume":"98","author":"AV Hoekstra","year":"2005","unstructured":"Hoekstra AV, Riben MW, Frumovitz M et al (2005) Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol 98:161\u2013167. https:\/\/doi.org\/10.1016\/J.YGYNO.2005.03.031","journal-title":"Gynecol Oncol"},{"key":"1683_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1309\/AJCPOTO9LBB4UKWC","volume":"142","author":"JG Nasit","year":"2014","unstructured":"Nasit JG, Dhruva G (2014) Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology. Am J Clin Pathol 142:233\u2013242. https:\/\/doi.org\/10.1309\/AJCPOTO9LBB4UKWC","journal-title":"Am J Clin Pathol"},{"key":"1683_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H (2019) Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health 11:287. https:\/\/doi.org\/10.2147\/IJWH.S197604","journal-title":"Int J Womens Health"},{"key":"1683_CR69","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","volume":"157","author":"MC Lim","year":"2022","unstructured":"Lim MC, Chang SJ, Park B et al (2022) Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial. JAMA Surg 157:374\u2013383. https:\/\/doi.org\/10.1001\/jamasurg.2022.0143","journal-title":"JAMA Surg"},{"key":"1683_CR70","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177:1053\u20131064. https:\/\/doi.org\/10.2353\/ajpath.2010.100105","journal-title":"Am J Pathol"},{"key":"1683_CR71","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","volume":"28","author":"A Malpica","year":"2004","unstructured":"Malpica A, Deavers MT, Lu K et al (2004) Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 28:496\u2013504. https:\/\/doi.org\/10.1097\/00000478-200404000-00009","journal-title":"Am J Surg Pathol"},{"key":"1683_CR72","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-21-0191","volume":"29","author":"T Moujaber","year":"2022","unstructured":"Moujaber T, Balleine RL, Gao B et al (2022) New therapeutic opportunities for women with low-grade serous ovarian cancer. Endocr Relat Cancer 29:R1\u2013R16. https:\/\/doi.org\/10.1530\/ERC-21-0191","journal-title":"Endocr Relat Cancer"},{"key":"1683_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.809773","volume":"12","author":"A Souadka","year":"2022","unstructured":"Souadka A, Essangri H, Majbar MA, Benkabbou A, Boutayeb S, You B, Glehen O, Mohsine R, Bakrin N (2022) Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in ovarian cancer: an umbrella review of meta-analyses. Front Oncol 12:809773. https:\/\/doi.org\/10.3389\/fonc.2022.809773","journal-title":"Front Oncol"},{"key":"1683_CR74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/J.YGYNO.2013.05.040","volume":"130","author":"SJ Chang","year":"2013","unstructured":"Chang SJ, Hodeib M, Chang J, Bristow RE (2013) Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol 130:493\u2013498. https:\/\/doi.org\/10.1016\/J.YGYNO.2013.05.040","journal-title":"Gynecol Oncol"},{"key":"1683_CR75","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK et al (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259. https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1248","journal-title":"J Clin Oncol"},{"key":"1683_CR76","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/J.YGYNO.2006.11.025","volume":"105","author":"JY Hou","year":"2007","unstructured":"Hou JY, Kelly MG, Yu H et al (2007) Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 105:211\u2013217. https:\/\/doi.org\/10.1016\/J.YGYNO.2006.11.025","journal-title":"Gynecol Oncol"},{"key":"1683_CR77","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","volume":"22","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E et al (2015) Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22:1570\u20131575. https:\/\/doi.org\/10.1245\/s10434-014-4157-9","journal-title":"Ann Surg Oncol"},{"key":"1683_CR78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","volume":"9","author":"M Markman","year":"1991","unstructured":"Markman M, Rothman R, Hakes T et al (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9:389\u2013393. https:\/\/doi.org\/10.1200\/JCO.1991.9.3.389","journal-title":"J Clin Oncol"},{"key":"1683_CR79","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1470-2045(20)30178-9","volume":"21","author":"RT Penson","year":"2020","unstructured":"Penson RT (2020) Platinum-sensitive ovarian cancer: liminal advances. Lancet Oncol 21:614\u2013615. https:\/\/doi.org\/10.1016\/S1470-2045(20)30178-9","journal-title":"Lancet Oncol"},{"issue":"10","key":"1683_CR80","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/S11912-008-0078-8","volume":"106","author":"KM Schmeler","year":"2008","unstructured":"Schmeler KM (2008) Gershenson DM (2008) Low-grade serous ovarian cancer: a unique disease. Curr Oncol Reports 106(10):519\u2013523. https:\/\/doi.org\/10.1007\/S11912-008-0078-8","journal-title":"Curr Oncol Reports"},{"key":"1683_CR81","first-page":"1311","volume":"63","author":"M Selvakumaran","year":"2003","unstructured":"Selvakumaran M, Pisarcik DA, Bao R et al (2003) Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 63:1311\u20131316","journal-title":"Cancer Res"},{"key":"1683_CR82","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMOA0908806\/SUPPL_FILE\/NEJMOA0908806_DISCLOSURES.PDF","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943\u2013953. https:\/\/doi.org\/10.1056\/NEJMOA0908806\/SUPPL_FILE\/NEJMOA0908806_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"1683_CR83","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMOA2103294\/SUPPL_FILE\/NEJMOA2103294_DATA-SHARING.PDF","volume":"385","author":"P Harter","year":"2021","unstructured":"Harter P, Sehouli J, Vergote I et al (2021) Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med 385:2123\u20132131. https:\/\/doi.org\/10.1056\/NEJMOA2103294\/SUPPL_FILE\/NEJMOA2103294_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"1683_CR84","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMOA1708618\/SUPPL_FILE\/NEJMOA1708618_DISCLOSURES.PDF","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230\u2013240. https:\/\/doi.org\/10.1056\/NEJMOA1708618\/SUPPL_FILE\/NEJMOA1708618_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"1683_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101928","volume":"42","author":"T Hong","year":"2021","unstructured":"Hong T, Lei G, Chen X, Li H, Zhang X, Wu N, Zhao Y, Zhang Y, Wang J (2021) PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol 42:101928. https:\/\/doi.org\/10.1016\/j.redox.2021.101928","journal-title":"Redox Biol"},{"issue":"1","key":"1683_CR86","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1002\/onco.13551","volume":"26","author":"S Arora","year":"2021","unstructured":"Arora S, Balasubramaniam S, Zhang H, Berman T, Narayan P, Suzman D, Bloomquist E, Tang S, Gong Y, Sridhara R, Turcu FR, Chatterjee D, Saritas-Yildirim B, Ghosh S, Philip R, Pathak A, Gao JJ, Amiri-Kordestani L, Pazdur R, Beaver JA (2021) FDA approval summary: olaparib monotherapy or in combination with bevacizumab for the maintenance treatment of patients with advanced ovarian cancer. Oncologist 26(1):e164\u2013e172. https:\/\/doi.org\/10.1002\/onco.13551","journal-title":"Oncologist"},{"key":"1683_CR87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/GCC.22935","volume":"60","author":"T Foo","year":"2021","unstructured":"Foo T, George A, Banerjee S (2021) PARP inhibitors in ovarian cancer: an overview of the practice-changing trials. Genes Chromosomes Cancer 60:385\u2013397. https:\/\/doi.org\/10.1002\/GCC.22935","journal-title":"Genes Chromosomes Cancer"},{"key":"1683_CR88","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","volume":"137","author":"KC Kurnit","year":"2021","unstructured":"Kurnit KC, Fleming GF, Lengyel E (2021) Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol 137:108\u2013121. https:\/\/doi.org\/10.1097\/AOG.0000000000004173","journal-title":"Obstet Gynecol"},{"key":"1683_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/J.BPOBGYN.2016.12.001","volume":"41","author":"T Grunewald","year":"2017","unstructured":"Grunewald T, Ledermann JA (2017) Targeted therapies for ovarian cancer. Best Pract Res Clin Obstet Gynaecol 41:139\u2013152. https:\/\/doi.org\/10.1016\/J.BPOBGYN.2016.12.001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1683_CR90","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/J.1440-1827.1996.TB03656.X","volume":"46","author":"K Nomura","year":"1996","unstructured":"Nomura K, Aizawa S (1996) Clinicopathologic and mucin histochemical analyses of 90 cases of ovarian mucinous borderline tumors of intestinal and m\u00fcllerian types. Pathol Int 46:575\u2013580. https:\/\/doi.org\/10.1111\/J.1440-1827.1996.TB03656.X","journal-title":"Pathol Int"},{"key":"1683_CR91","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000356072","volume":"76","author":"T Song","year":"2013","unstructured":"Song T, Choi CH, Lee YY et al (2013) Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics. Gynecol Obstet Invest 76:241\u2013247. https:\/\/doi.org\/10.1159\/000356072","journal-title":"Gynecol Obstet Invest"},{"key":"1683_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/modpathol.3800307","volume":"18","author":"WR Hart","year":"2005","unstructured":"Hart WR (2005) Borderline epithelial tumors of the ovary. Mod Pathol 18:33\u201350. https:\/\/doi.org\/10.1038\/modpathol.3800307","journal-title":"Mod Pathol"},{"key":"1683_CR93","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1097\/00000478-200011000-00001","volume":"24","author":"KR Lee","year":"2000","unstructured":"Lee KR, Scully RE (2000) Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with \u201cpseudomyxoma peritonei.\u201d Am J Surg Pathol 24:1447\u20131464. https:\/\/doi.org\/10.1097\/00000478-200011000-00001","journal-title":"Am J Surg Pathol"},{"key":"1683_CR94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1245\/S10434-010-1293-8","volume":"18","author":"M Koskas","year":"2011","unstructured":"Koskas M, Uzan C, Gouy S et al (2011) Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol 18:40\u201348. https:\/\/doi.org\/10.1245\/S10434-010-1293-8","journal-title":"Ann Surg Oncol"},{"key":"1683_CR95","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","volume":"19","author":"G Zanetta","year":"2001","unstructured":"Zanetta G, Rota S, Chiari S et al (2001) Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 19:2658\u20132664. https:\/\/doi.org\/10.1200\/JCO.2001.19.10.2658","journal-title":"J Clin Oncol"},{"key":"1683_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/ANNUREV-PATHOL-020712-163949","volume":"9","author":"NN Nik","year":"2014","unstructured":"Nik NN, Vang R, Shih IM, Kurman RJ (2014) Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu Rev Pathol 9:27\u201345. https:\/\/doi.org\/10.1146\/ANNUREV-PATHOL-020712-163949","journal-title":"Annu Rev Pathol"},{"key":"1683_CR97","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/S12253-011-9375-X\/TABLES\/3","volume":"17","author":"Q Liu","year":"2011","unstructured":"Liu Q, Lin JX, Shi QL et al (2011) Primary peritoneal serous papillary carcinoma: a clinical and pathological study. Pathol Oncol Res 17:713\u2013719. https:\/\/doi.org\/10.1007\/S12253-011-9375-X\/TABLES\/3","journal-title":"Pathol Oncol Res"},{"key":"1683_CR98","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0046-8177(90)90050-F","volume":"21","author":"N Khoury","year":"1990","unstructured":"Khoury N, Raju U, Crissman JD et al (1990) A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas. Hum Pathol 21:811\u2013819. https:\/\/doi.org\/10.1016\/0046-8177(90)90050-F","journal-title":"Hum Pathol"},{"key":"1683_CR99","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/(SICI)1096-9896(199812)186:4","volume":"186","author":"DJ Ruiter","year":"1998","unstructured":"Ruiter DJ, Van Muijen GNP (1998) Markers of melanocytic tumour progression. J Pathol 186:340\u2013342. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199812)186:4","journal-title":"J Pathol"},{"issue":"3","key":"1683_CR100","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/1097-0142(19950801)76:3<429::aid-cncr2820760313>3.0.co;2-8","volume":"76","author":"J Zhou","year":"1995","unstructured":"Zhou J, Iwasa Y, Konishi I, Kan N, Kannagi R, Kobashi Y, Kim YC, Yamabe H (1995) Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study. Cancer 76(3):429\u2013436. https:\/\/doi.org\/10.1002\/1097-0142(19950801)76:3<429::aid-cncr2820760313>3.0.co;2-8","journal-title":"Cancer"},{"key":"1683_CR101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0090-8258(03)00068-4","volume":"89","author":"JD Bloss","year":"2003","unstructured":"Bloss JD, Brady MF, Liao SY et al (2003) Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma - A Gynecologic Oncology Group Study. Gynecol Oncol 89:148\u2013154. https:\/\/doi.org\/10.1016\/S0090-8258(03)00068-4","journal-title":"Gynecol Oncol"},{"key":"1683_CR102","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/J.SOC.2007.04.017","volume":"16","author":"E Suh-Burgmann","year":"2007","unstructured":"Suh-Burgmann E, Powell CB (2007) Cytoreductive surgery for gynecologic malignancies\u2013new standards of care. Surg Oncol Clin N Am 16:667\u2013682. https:\/\/doi.org\/10.1016\/J.SOC.2007.04.017","journal-title":"Surg Oncol Clin N Am"},{"key":"1683_CR103","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.ejso.2019.06.021","volume":"45","author":"M Deraco","year":"2019","unstructured":"Deraco M, Sinukumar S, Salcedo-Hern\u00e1ndez RA et al (2019) Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy-largest single institute experience. Eur J Surg Oncol 45:2103\u20132108. https:\/\/doi.org\/10.1016\/j.ejso.2019.06.021","journal-title":"Eur J Surg Oncol"},{"key":"1683_CR104","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/0022-3468(91)90607-U","volume":"26","author":"MA Kosir","year":"1991","unstructured":"Kosir MA, Sonnino RE, Gauderer MWL (1991) Pediatric abdominal lymphangiomas. J Pediatr Surg 26:1309\u20131313","journal-title":"J Pediatr Surg"},{"key":"1683_CR105","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0022-3468(96)90673-9","volume":"31","author":"H Steyaert","year":"1996","unstructured":"Steyaert H, Guitard J, Moscovici J et al (1996) Abdominal cystic lymphangioma in children: benign lesions that can have a proliferative course. J Pediatr Surg 31:677\u2013680. https:\/\/doi.org\/10.1016\/S0022-3468(96)90673-9","journal-title":"J Pediatr Surg"},{"key":"1683_CR106","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.humpath.2005.02.007","volume":"36","author":"JL Hornick","year":"2005","unstructured":"Hornick JL, Fletcher CDM (2005) Intraabdominal cystic lymphangiomas obscured by marked superimposed reactive changes: clinicopathological analysis of a series. Hum Pathol 36:426\u2013432. https:\/\/doi.org\/10.1016\/j.humpath.2005.02.007","journal-title":"Hum Pathol"},{"key":"1683_CR107","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/S00268-012-1515-2\/TABLES\/2","volume":"36","author":"A Makni","year":"2012","unstructured":"Makni A, Chebbi F, Fetirich F et al (2012) Surgical management of intra-abdominal cystic lymphangioma. Report of 20 cases. World J Surg 36:1037\u20131043. https:\/\/doi.org\/10.1007\/S00268-012-1515-2\/TABLES\/2","journal-title":"World J Surg"},{"key":"1683_CR108","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/J.HOC.2013.07.002","volume":"27","author":"C Serrano","year":"2013","unstructured":"Serrano C, George S (2013) Leiomyosarcoma. Hematol Oncol Clin North Am 27:957\u2013974. https:\/\/doi.org\/10.1016\/J.HOC.2013.07.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"1683_CR109","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","volume":"17","author":"M Van Glabbeke","year":"1999","unstructured":"Van Glabbeke M, Van Oosterom AT, Oosterhuis JW et al (1999) Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens\u2013a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 17:150\u2013157. https:\/\/doi.org\/10.1200\/JCO.1999.17.1.150","journal-title":"J Clin Oncol"},{"key":"1683_CR110","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/S00428-004-1055-8\/FIGURES\/5","volume":"445","author":"U Yamaguchi","year":"2004","unstructured":"Yamaguchi U, Hasegawa T, Masuda T et al (2004) Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 445:142\u2013150. https:\/\/doi.org\/10.1007\/S00428-004-1055-8\/FIGURES\/5","journal-title":"Virchows Arch"},{"key":"1683_CR111","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/ANNONC\/MDR610","volume":"23","author":"I Ray-coquard","year":"2012","unstructured":"Ray-coquard I, Montesco MC, Coindre JM et al (2012) Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol Off J Eur Soc Med Oncol 23:2442\u20132449. https:\/\/doi.org\/10.1093\/ANNONC\/MDR610","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"1683_CR112","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/J.ANNONC.2021.07.006\/ATTACHMENT\/A9170587-4D5D-4FB1-A159-D8A0A7B53BF9\/MMC1.PDF","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi A, Miah AB, Dei Tos AP et al (2021) Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol 32:1348\u20131365. https:\/\/doi.org\/10.1016\/J.ANNONC.2021.07.006\/ATTACHMENT\/A9170587-4D5D-4FB1-A159-D8A0A7B53BF9\/MMC1.PDF","journal-title":"Ann Oncol"},{"key":"1683_CR113","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/J.CRITREVONC.2016.12.002","volume":"110","author":"E Andritsch","year":"2017","unstructured":"Andritsch E, Beishon M, Bielack S et al (2017) ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol 110:94\u2013105. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2016.12.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"1683_CR114","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8547173","author":"A Gojayev","year":"2016","unstructured":"Gojayev A, English DP, Macer M, Azodi M (2016) Chlamydia peritonitis and ascites mimicking ovarian cancer. Case Rep Obstet Gynecol. https:\/\/doi.org\/10.1155\/2016\/8547173","journal-title":"Case Rep Obstet Gynecol"},{"key":"1683_CR115","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","volume":"19","author":"L Westr\u00f6m","year":"1992","unstructured":"Westr\u00f6m L, Joesoef R, Reynolds G et al (1992) Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19:185\u2013192. https:\/\/doi.org\/10.1097\/00007435-199207000-00001","journal-title":"Sex Transm Dis"},{"key":"1683_CR116","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.IJGO.2015.11.028","volume":"134","author":"JL Brun","year":"2016","unstructured":"Brun JL, Graesslin O, Fauconnier A et al (2016) Updated French guidelines for diagnosis and management of pelvic inflammatory disease. Int J Gynecol Obstet 134:121\u2013125. https:\/\/doi.org\/10.1016\/J.IJGO.2015.11.028","journal-title":"Int J Gynecol Obstet"},{"key":"1683_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/847041","volume":"2010","author":"J DeWitt","year":"2010","unstructured":"DeWitt J, Reining A, Allsworth JE, Peipert JF (2010) Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int 2010:1\u20135. https:\/\/doi.org\/10.1155\/2010\/847041","journal-title":"Obstet Gynecol Int"},{"key":"1683_CR118","first-page":"101","volume":"58","author":"Y Greenstein","year":"2013","unstructured":"Greenstein Y, Shah AJ, Vragovic O et al (2013) Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy. J Reprod Med 58:101\u2013106","journal-title":"J Reprod Med"},{"key":"1683_CR119","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/605559\/2\/49-9-1350-FIG002.GIF","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA et al (2009) Epidemiology of extrapulmonary tuberculosis in the United States, 1993\u20132006. Clin Infect Dis 49:1350\u20131357. https:\/\/doi.org\/10.1086\/605559\/2\/49-9-1350-FIG002.GIF","journal-title":"Clin Infect Dis"},{"key":"1683_CR120","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/J.1365-2036.2005.02645.X","volume":"22","author":"FM Sanai","year":"2005","unstructured":"Sanai FM, Bzeizi KI (2005) Systematic review: tuberculous peritonitis \u2013 presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 22:685\u2013700. https:\/\/doi.org\/10.1111\/J.1365-2036.2005.02645.X","journal-title":"Aliment Pharmacol Ther"},{"key":"1683_CR121","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/01.AOG.0000295653.32975.4A","volume":"110","author":"RG Elmore","year":"2007","unstructured":"Elmore RG, Li AJ, Nygaard I (2007) Peritoneal tuberculosis mimicking advanced-stage epithelial ovarian cancer. Obstet Gynecol 110:1417\u20131419. https:\/\/doi.org\/10.1097\/01.AOG.0000295653.32975.4A","journal-title":"Obstet Gynecol"},{"key":"1683_CR122","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/J.YGYNO.2006.04.010","volume":"103","author":"S Koc","year":"2006","unstructured":"Koc S, Beydilli G, Tulunay G et al (2006) Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases. Gynecol Oncol 103:565\u2013569. https:\/\/doi.org\/10.1016\/J.YGYNO.2006.04.010","journal-title":"Gynecol Oncol"},{"key":"1683_CR123","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/S00404-009-1295-6","volume":"282","author":"JB Sharma","year":"2010","unstructured":"Sharma JB, Jain SK, Pushparaj M et al (2010) Abdomino-peritoneal tuberculosis masquerading as ovarian cancer: a retrospective study of 26 cases. Arch Gynecol Obstet 282:643\u2013648. https:\/\/doi.org\/10.1007\/S00404-009-1295-6","journal-title":"Arch Gynecol Obstet"},{"key":"1683_CR124","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/IJGC-00009577-200107000-00006","volume":"11","author":"T Bilgin","year":"2001","unstructured":"Bilgin T, Karabay A, Dolar E et al (2001) Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases. Int J Gynecol Cancer 11:290\u2013294. https:\/\/doi.org\/10.1136\/IJGC-00009577-200107000-00006","journal-title":"Int J Gynecol Cancer"},{"key":"1683_CR125","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/1354750X.2015.1118552","volume":"21","author":"L Zhang","year":"2016","unstructured":"Zhang L, Chen Y, Liu W, Wang K (2016) Evaluating the clinical significances of serum HE4 with CA125 in peritoneal tuberculosis and epithelial ovarian cancer. Biomarkers 21:168\u2013172. https:\/\/doi.org\/10.3109\/1354750X.2015.1118552","journal-title":"Biomarkers"},{"issue":"3","key":"1683_CR126","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1148\/radiographics.20.3.g00ma06795","volume":"20","author":"I Pedrosa","year":"2000","unstructured":"Pedrosa I, Sa\u00edz A, Arrazola J, Ferreir\u00f3s J, Pedrosa CS (2000) Hydatid disease: radiologic and pathologic features and complications. Radiographics: a review publication of the Radiological Society of North America, Inc 20(3):795\u2013817. https:\/\/doi.org\/10.1148\/radiographics.20.3.g00ma06795","journal-title":"Radiographics : a review publication of the Radiological Society of North America, Inc"},{"key":"1683_CR127","doi-asserted-by":"publisher","unstructured":"Hegde N, Hiremath B (2013) Primary peritoneal hydatidosis. BMJ Case Rep 2013:bcr2013200435. https:\/\/doi.org\/10.1136\/BCR-2013-200435","DOI":"10.1136\/BCR-2013-200435"},{"key":"1683_CR128","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/ajcp\/aqaa189","volume":"155","author":"G Karpathiou","year":"2021","unstructured":"Karpathiou G, Casteillo F, Dridi M, Peoc\u2019h M (2021) Mesothelial cysts. Am J Clin Pathol 155:853\u2013862. https:\/\/doi.org\/10.1093\/ajcp\/aqaa189","journal-title":"Am J Clin Pathol"},{"key":"1683_CR129","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1245\/S10434-007-9475-8\/TABLES\/3","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Nonaka D et al (2007) Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol 14:2790\u20132797. https:\/\/doi.org\/10.1245\/S10434-007-9475-8\/TABLES\/3","journal-title":"Ann Surg Oncol"},{"key":"1683_CR130","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/030089160308900107","volume":"89","author":"K Sethna","year":"2003","unstructured":"Sethna K, Mohamed F, Marchettini P et al (2003) Peritoneal cystic mesothelioma: a case series. Tumori 89:31\u201335. https:\/\/doi.org\/10.1177\/030089160308900107","journal-title":"Tumori"},{"key":"1683_CR131","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4103\/JCRT.JCRT_125_16","volume":"13","author":"MK Eryilmaz","year":"2017","unstructured":"Eryilmaz MK, Mutlu H, Tazegul G et al (2017) Multiple pelvic cysts in a patient with familial Mediterranean fever: benign cystic mesothelioma. J Cancer Res Ther 13:1047. https:\/\/doi.org\/10.4103\/JCRT.JCRT_125_16","journal-title":"J Cancer Res Ther"},{"key":"1683_CR132","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/ART.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879\u20131885. https:\/\/doi.org\/10.1002\/ART.1780401023","journal-title":"Arthritis Rheum"},{"key":"1683_CR133","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00000478-200104000-00003","volume":"25","author":"RK Yantiss","year":"2001","unstructured":"Yantiss RK, Clement PB, Young RH (2001) Endometriosis of the intestinal tract: a study of 44 cases of a disease that may cause diverse challenges in clinical and pathologic evaluation. Am J Surg Pathol 25:445\u2013454. https:\/\/doi.org\/10.1097\/00000478-200104000-00003","journal-title":"Am J Surg Pathol"},{"key":"1683_CR134","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.JMIG.2010.09.002","volume":"18","author":"GA Vilos","year":"2011","unstructured":"Vilos GA, Hollett-Caines J, Abu-Rafea B et al (2011) Resolution of catamenial epilepsy after goserelin therapy and oophorectomy: case report of presumed cerebral endometriosis. J Minim Invasive Gynecol 18:128\u2013130. https:\/\/doi.org\/10.1016\/J.JMIG.2010.09.002","journal-title":"J Minim Invasive Gynecol"},{"key":"1683_CR135","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/J.FERTNSTERT.2006.04.054","volume":"86","author":"K Ballard","year":"2006","unstructured":"Ballard K, Lowton K, Wright J (2006) What\u2019s the delay? A qualitative study of women\u2019s experiences of reaching a diagnosis of endometriosis. Fertil Steril 86:1296\u20131301. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2006.04.054","journal-title":"Fertil Steril"},{"key":"1683_CR136","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.AJOG.2019.02.033","volume":"221","author":"S As-Sanie","year":"2019","unstructured":"As-Sanie S, Black R, Giudice LC et al (2019) Assessing research gaps and unmet needs in endometriosis. Am J Obstet Gynecol 221:86\u201394. https:\/\/doi.org\/10.1016\/J.AJOG.2019.02.033","journal-title":"Am J Obstet Gynecol"},{"key":"1683_CR137","doi-asserted-by":"publisher","unstructured":"Nisenblat V, Bossuyt PM, Farquhar C, et al (2016) Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane database Syst Rev 2:CD009591. https:\/\/doi.org\/10.1002\/14651858.CD009591.PUB2","DOI":"10.1002\/14651858.CD009591.PUB2"},{"key":"1683_CR138","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/S00261-019-02381-W\/FIGURES\/19","volume":"45","author":"BR Mason","year":"2020","unstructured":"Mason BR, Chatterjee D, Menias CO et al (2020) Encyclopedia of endometriosis: a pictorial rad-path review. Abdom Radiol 45:1587\u20131607. https:\/\/doi.org\/10.1007\/S00261-019-02381-W\/FIGURES\/19","journal-title":"Abdom Radiol"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-022-01683-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-022-01683-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-022-01683-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T15:25:05Z","timestamp":1687361105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-022-01683-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":138,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1007\/s13193-022-01683-8","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"value":"0975-7651","type":"print"},{"value":"0976-6952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}